Stericycle Inc (SRCL) is Downgraded by RBC Capital Mkts to Underperform, Lowers Price Target to $ 96

Stericycle Inc (SRCL) was Downgraded by RBC Capital Mkts to ” Underperform” while Lowering the Price Target of the company shares to $ 96 from a previous price target of $119 . Earlier the firm had a rating of “Sector Perform ” on the company shares. RBC Capital Mkts advised their investors in a research report released on Apr 29, 2016.

Many Wall Street Analysts have commented on Stericycle Inc. Stericycle Inc was Initiated by Sterne Agee CRT to “Buy” on Mar 22, 2016. Shares were Reiterated by Imperial Capital on Feb 8, 2016 to “In-line” and Lowered the Price Target to $ 115 from a previous price target of $135 .Shares were Reiterated by RBC Capital Mkts on Feb 8, 2016 to “Sector Perform” and Lowered the Price Target to $ 119 from a previous price target of $120 .

On the company’s financial health, Stericycle Inc reported $1.11 EPS for the quarter, beating the analyst consensus estimate by $ 0.03 according to the earnings call on Feb 4, 2016. Analyst had a consensus of $1.08. The company had revenue of $888.30 million for the quarter, compared to analysts expectations of $899.78 million. The company’s revenue was up 31.2% compared to the same quarter last year. During the same quarter in the previous year, the company posted $1.12 EPS.

Stericycle Inc opened for trading at $122.41 and hit $123.7 on the upside on Wednesday, eventually ending the session at $122.99, with a gain of 0.32% or 0.39 points. The heightened volatility saw the trading volume jump to 14,43,059 shares. Company has a market cap of $10,411 M.

In a different news, on Feb 23, 2016, Daniel Ginnetti (Chief Financial Officer) sold 17,184 shares at $110.75 per share price. According to the SEC, on Dec 15, 2015, John P Schetz (EVP & General Counsel) sold 1,190 shares at $116.34 per share price. On Aug 19, 2015, Rodney F Dammeyer (director) sold 8,500 shares at $147.28 per share price, according to the Form-4 filing with the securities and exchange commission.

Stericycle Inc. is engaged in the business of providing regulated and compliance solutions to healthcare and commercial businesses. The Company’s solutions include the collection and processing of specialized waste for disposal and a variety of training consulting recall/return communication and compliance services which include training consulting inbound/outbound communications data reporting and other regulatory compliance services. The Company operates regulated waste management networks in the United States Argentina Brazil Canada Chile Ireland Japan Mexico Portugal Romania South Korea Spain and the United Kingdom. The Company operates through two segments: United States and International. The Company’s networks include a total of 181 processing facilities 214 transfer sites and 97 other service facilities. Its regulated waste processing technology is primarily autoclaving. The Company also uses incineration and electro-thermal-deactivation system (ETD).

Stericycle Inc

Leave a Reply

Stericycle Inc - Is it time to Sell?

Top Brokerage Firms are advising their investors on Stericycle Inc. Subscribe to MoneyFlowIndex.Org Pre-Market Alerts, You will be the first to know the street buzz.